Sterling Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 17	Mar ' 16	Dec ' 14	Dec ' 13	Dec ' 12

Sources of funds

Owner's fund

Equity share capital

27.22

27.22

27.20

26.79

26.79

Share application money

-

-

-

-

-

Preference share capital

1,912.60

1,854.04

1,506.83

-

-

Reserves & surplus

1,248.87

1,636.53

1,010.26

1,443.34

1,843.99

Loan funds

Secured loans

3,037.12

3,244.48

1,768.41

2,640.31

2,609.14

Unsecured loans

-

-

1,274.45

-

-

Total

6,225.81

6,762.26

5,587.15

4,110.43

4,479.92

Uses of funds

Fixed assets

Gross block

3,287.53

3,283.48

5,021.26

4,926.18

4,871.93

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

561.24

318.92

1,747.42

1,492.74

1,238.80

Net block

2,726.29

2,964.55

3,273.84

3,433.44

3,633.13

Capital work-in-progress

2,442.30

2,449.75

2,270.13

2,109.79

1,551.81

Investments

1,582.07

1,552.44

168.91

376.52

376.51

Net current assets

Current assets, loans & advances

1,604.43

1,393.48

1,499.66

1,479.08

1,522.22

Less : current liabilities & provisions

2,129.28

1,597.97

1,625.38

3,288.40

2,603.76

Total net current assets

-524.85

-204.48

-125.72

-1,809.31

-1,081.54

Miscellaneous expenses not written

-

-

-

-

-

Total

6,225.81

6,762.26

5,587.15

4,110.43

4,479.92

Notes:

Book value of unquoted investments

1,579.81

1,550.77

164.37

371.98

371.97

Market value of quoted investments

-

-

1.75

1.24

1.09

Contingent liabilities

105.74

100.51

0.92

82.86

8.86

Number of equity sharesoutstanding (Lacs)

2721.70

2721.70

2720.48

2678.74

2678.74